171 related articles for article (PubMed ID: 16420478)
1. Cholesterol and its anionic derivatives inhibit 5-lipoxygenase activation in polymorphonuclear leukocytes and MonoMac6 cells.
Aleksandrov DA; Zagryagskaya AN; Pushkareva MA; Bachschmid M; Peters-Golden M; Werz O; Steinhilber D; Sud'ina GF
FEBS J; 2006 Feb; 273(3):548-57. PubMed ID: 16420478
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of leukotriene B4 in human polymorphonuclear leukocytes: regulation by cholesterol and other lipids.
Zagryagskaya AN; Aleksandrov DA; Pushkareva MA; Galkina SI; Grishina ZV; Sud'ina GF
J Immunotoxicol; 2008 Oct; 5(4):347-52. PubMed ID: 19404868
[TBL] [Abstract][Full Text] [Related]
3. [Suppression of 5-lipoxygenase activity by anionic cholesterol derivatives].
Aleksandov DA; Sud'ina GF
Biomed Khim; 2006; 52(5):511-7. PubMed ID: 17180926
[TBL] [Abstract][Full Text] [Related]
4. Eugenol--the active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells.
Raghavenra H; Diwakr BT; Lokesh BR; Naidu KA
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):23-7. PubMed ID: 16216483
[TBL] [Abstract][Full Text] [Related]
5. Sulfatides inhibit leukotriene synthesis in human polymorphonuclear granulocytes by a mechanism involving lipid rearrangement in intracellular membranes.
Grishina ZV; Pushkareva MA; Pletjushkina OY; Reiser G; Peters-Golden M; Sud'ina GF
Int J Biochem Cell Biol; 2008; 40(1):110-24. PubMed ID: 17822942
[TBL] [Abstract][Full Text] [Related]
6. Hypertonicity suppresses ionophore-induced product formation and translocation of 5-lipoxygenase in human leukocytes.
Bürkert E; Rådmark O; Samuelsson B; Steinhilber D; Werz O
J Leukoc Biol; 2002 Mar; 71(3):477-86. PubMed ID: 11867685
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester up-regulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human polymorphonuclear leukocytes.
Werz O; Klemm J; Samuelsson B; Rådmark O
Blood; 2001 Apr; 97(8):2487-95. PubMed ID: 11290614
[TBL] [Abstract][Full Text] [Related]
8. Decreased leukotriene C4 synthesis accompanies adherence-dependent nuclear import of 5-lipoxygenase in human blood eosinophils.
Brock TG; Anderson JA; Fries FP; Peters-Golden M; Sporn PH
J Immunol; 1999 Feb; 162(3):1669-76. PubMed ID: 9973428
[TBL] [Abstract][Full Text] [Related]
9. The role of diacylglyceride generation by phospholipase D and phosphatidic acid phosphatase in the activation of 5-lipoxygenase in polymorphonuclear leukocytes.
Albert D; Pergola C; Koeberle A; Dodt G; Steinhilber D; Werz O
J Leukoc Biol; 2008 Apr; 83(4):1019-27. PubMed ID: 18218859
[TBL] [Abstract][Full Text] [Related]
10. Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes.
Werz O; Bürkert E; Fischer L; Szellas D; Dishart D; Samuelsson B; Rådmark O; Steinhilber D
FASEB J; 2002 Sep; 16(11):1441-3. PubMed ID: 12205041
[TBL] [Abstract][Full Text] [Related]
11. Enhancement by GM-CSF of agonist-induced 5-lipoxygenase activation in human neutrophils involves protein synthesis and gene transcription.
McDonald PP; Pouliot M; Borgeat P
J Lipid Mediat; 1993; 6(1-3):59-67. PubMed ID: 8358016
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes.
Boudreau LH; Maillet J; LeBlanc LM; Jean-François J; Touaibia M; Flamand N; Surette ME
PLoS One; 2012; 7(2):e31833. PubMed ID: 22347509
[TBL] [Abstract][Full Text] [Related]
13. Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.
Fischer L; Steinhilber D; Werz O
Br J Pharmacol; 2004 Jul; 142(5):861-8. PubMed ID: 15197110
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel 2-amino-5-hydroxyindole derivatives that inhibit human 5-lipoxygenase.
Landwehr J; George S; Karg EM; Poeckel D; Steinhilber D; Troschuetz R; Werz O
J Med Chem; 2006 Jul; 49(14):4327-32. PubMed ID: 16821792
[TBL] [Abstract][Full Text] [Related]
15. Development of 5-lipoxygenase inhibitors--lessons from cellular enzyme regulation.
Werz O; Steinhilber D
Biochem Pharmacol; 2005 Aug; 70(3):327-33. PubMed ID: 15907806
[TBL] [Abstract][Full Text] [Related]
16. The expression of cytosolic phospholipase A2 and biosynthesis of leukotriene B4 in acute myeloid leukemia cells.
Runarsson G; Feltenmark S; Forsell PK; Sjöberg J; Björkholm M; Claesson HE
Eur J Haematol; 2007 Dec; 79(6):468-76. PubMed ID: 17976189
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of actin polymerisation stimulate arachidonic acid release and 5-lipoxygenase activation by upregulation of Ca2+ mobilisation in polymorphonuclear leukocytes involving Src family kinases.
Fischer L; Poeckel D; Buerkert E; Steinhilber D; Werz O
Biochim Biophys Acta; 2005 Sep; 1736(2):109-19. PubMed ID: 16126002
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis.
Rådmark O; Samuelsson B
Biochem Biophys Res Commun; 2010 May; 396(1):105-10. PubMed ID: 20494120
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human 5-lipoxygenase activity by membrane lipids.
Pande AH; Moe D; Nemec KN; Qin S; Tan S; Tatulian SA
Biochemistry; 2004 Nov; 43(46):14653-66. PubMed ID: 15544336
[TBL] [Abstract][Full Text] [Related]
20. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
